Stocks and Investing
Stocks and Investing
Thu, August 22, 2024
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
Ronald Kamdem Maintained (AHR) at Buy with Increased Target to $22 on, Aug 22nd, 2024
Ronald Kamdem of Morgan Stanley, Maintained "American Healthcare REIT, Inc." (AHR) at Buy with Increased Target from $17 to $22 on, Aug 22nd, 2024.
Ronald has made no other calls on AHR in the last 4 months.
There are 3 other peers that have a rating on AHR. Out of the 3 peers that are also analyzing AHR, 0 agree with Ronald's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ronald
- Joshua Dennerlein of "B of A Securities" Maintained at Strong Buy with Increased Target to $27 on, Tuesday, August 20th, 2024
- Aaron Hecht of "JMP Securities" Maintained at Buy with Increased Target to $18 on, Wednesday, August 7th, 2024
- Michael Lewis of "Truist Securities" Reiterated at Strong Buy with Increased Target to $17 on, Monday, July 1st, 2024
Contributing Sources